Xarelto (rivaroxaban)

pCPA File Number: 20785
Negotiation Status:
Concluded with an LOI
Indication(s):
Atrial fibrillation, stroke prevention
Sponsor/Manufacturer:
Bayer Inc.
CDA-AMC Project Number:
SR0257-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: